Pharmacologic agents for perioperative cardioprotection in noncardiac surgery
Authors:
- 11 April 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 38 (4) , 361-368
Abstract
Purpose of the review: This review will discuss the current pharmacologic strategies for mitigation of perioperative myocardial injury. State-of-the-art benefits and harms of pharmacologic interventions to delineate knowledge gaps in current guidelines and clinical practice will be presented. Recent findings: Beta-blockers are known to reduce major adverse cardiac events but inappropriate preoperative initiation results in adverse outcomes. Renin-Angiotensin-Aldosteron System (RAAS) inhibitors once universally discontinued before surgery are now under reconsideration as continuation seems not to be associated with increased risk. Statins continue to be the cornerstone due to their pleiotropic effect. Continuation of aspirin is supported perioperatively if the bleeding risk due to surgery is low to moderate. A few studies have investigated a strategy of strict intraoperative blood pressure control but failed to observe a meaningful effect on outcome. Whether prompt intensification of treatment in case of diagnosis of myocardial injury after noncardiac surgery improves outcome remains to be established. Since the MANAGE trial, no new studies have prospectively addressed this question. Summary: New data have questioned previous ideas and suggest a more nuanced, personalized approach to perioperative management. Accordingly, future studies should address refinement in risk stratification, optimization of pharmacologic strategies, and the development of novel therapies in attempting to enhance outcomes in high-risk surgical populations.Keywords
This publication has 37 references indexed in Scilit:
- Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac SurgeryJAMA, 2024
- Pathophysiological mechanisms underlying increased circulating cardiac troponin in noncardiac surgery: a narrative reviewBritish Journal of Anaesthesia, 2024
- Patients with Prior Exposure to a Combination of Statins & Angiotensin-Converting Enzyme Inhibitors (ACE-Is)/Angiotensin Receptor Blockers (ARBs) Have Better Outcomes after Carotid Revascularization than Patients with Prior Exposure to Statins Alone: A MultiCenter AnalysisAnnals of Vascular Surgery, 2023
- Intraoperative hypotension and postoperative outcomes: a meta-analysis of randomised trialsBritish Journal of Anaesthesia, 2023
- Hypotension as a marker or mediator of perioperative organ injury: a narrative reviewBritish Journal of Anaesthesia, 2022
- High-sensitivity cardiac troponin T in young, healthy adults undergoing non-cardiac surgeryBritish Journal of Anaesthesia, 2018
- Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major SurgeryJAMA, 2017
- Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac SurgeryJAMA, 2017
- Does cardiology intervention improve mortality for post-operative troponin elevations after emergency orthopaedic–geriatric surgery? A randomised controlled studyInjury, 2012
- Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac SurgeryJAMA, 2012